Achilles Therapeutics Statistics
Total Valuation
CYD has a market cap or net worth of $1.08 billion. The enterprise value is $995.26 million.
Important Dates
The last earnings date was Friday, August 8, 2025, before market open.
| Earnings Date | Aug 8, 2025 |
| Ex-Dividend Date | Jun 25, 2025 |
Share Statistics
CYD has 37.52 million shares outstanding. The number of shares has decreased by -7.86% in one year.
| Current Share Class | 37.52M |
| Shares Outstanding | 37.52M |
| Shares Change (YoY) | -7.86% |
| Shares Change (QoQ) | -7.50% |
| Owned by Insiders (%) | 0.81% |
| Owned by Institutions (%) | 6.15% |
| Float | 7.87M |
Valuation Ratios
The trailing PE ratio is 17.30 and the forward PE ratio is 18.15. CYD's PEG ratio is 1.26.
| PE Ratio | 17.30 |
| Forward PE | 18.15 |
| PS Ratio | 0.34 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 1.26 |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 15.90 |
| EV / Sales | 0.32 |
| EV / EBITDA | 5.17 |
| EV / EBIT | 10.29 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 10.61 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | $353,796 |
| Profits Per Employee | $7,011 |
| Employee Count | 8,930 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CYD has paid $19.89 million in taxes.
| Income Tax | 19.89M |
| Effective Tax Rate | 17.12% |
Stock Price Statistics
The stock price has increased by +205.20% in the last 52 weeks. The beta is 1.02, so CYD's price volatility has been similar to the market average.
| Beta (5Y) | 1.02 |
| 52-Week Price Change | +205.20% |
| 50-Day Moving Average | 22.35 |
| 200-Day Moving Average | 15.91 |
| Relative Strength Index (RSI) | 73.10 |
| Average Volume (20 Days) | 256,032 |
Short Selling Information
| Short Interest | 390,252 |
| Short Previous Month | 239,771 |
| Short % of Shares Out | 5.30% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.80 |
Income Statement
In the last 12 months, CYD had revenue of $3.16 billion and earned $62.61 million in profits. Earnings per share was $1.66.
| Revenue | 3.16B |
| Gross Profit | 454.12M |
| Operating Income | 96.70M |
| Pretax Income | 60.49M |
| Net Income | 62.61M |
| EBITDA | 192.61M |
| EBIT | 96.70M |
| Earnings Per Share (EPS) | $1.66 |
Full Income StatementBalance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | n/a |
| Net Cash | n/a |
| Net Cash Per Share | n/a |
| Equity (Book Value) | n/a |
| Book Value Per Share | n/a |
| Working Capital | n/a |
Full Balance SheetMargins
Gross margin is 14.37%, with operating and profit margins of 3.06% and 1.98%.
| Gross Margin | 14.37% |
| Operating Margin | 3.06% |
| Pretax Margin | 3.68% |
| Profit Margin | 1.98% |
| EBITDA Margin | 6.10% |
| EBIT Margin | 3.06% |
| FCF Margin | n/a |
